Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis

The heterogeneity of lung adenocarcinoma is driven by key mutations in oncogenes. To determine the gene expression, single nucleotide polymorphisms, and co-mutations participating in the initiation and progression of lung adenocarcinoma, we comprehensively analyzed the data of 491 patients from The...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Mol Biosci
Egile Nagusiak: Zheng, Chang, Li, Xuelian, Ren, Yangwu, Yin, Zhihua, Zhou, Baosen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Molecular Biosciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056714/
https://ncbi.nlm.nih.gov/pubmed/32175330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00030
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak